Citigroup
CLOV icon

Citigroup’s Clover Health Investments CLOV Stock Holding History

Citigroup’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Buy
223,265
+187,181
+519% +$636K ﹤0.01% 3328
2026
Q1 		$63.5K Buy
36,084
+20,438
+131% +$44.3K ﹤0.01% 4433
2025
Q4 		$36.8K Sell
15,646
-41,851
-73% -$114K ﹤0.01% 4677
2025
Q3 		$176K Sell
57,497
-142,148
-71% -$406K ﹤0.01% 4046
2025
Q2 		$557K Buy
199,645
+177,711
+810% +$584K ﹤0.01% 3556
2025
Q1 		$78.7K Sell
21,934
-50,082
-70% -$201K ﹤0.01% 4722
2024
Q4 		$227K Sell
72,016
-236,556
-77% -$845K ﹤0.01% 4342
2024
Q3 		$870K Buy
308,572
+298,488
+2,960% +$683K ﹤0.01% 3363
2024
Q2 		$12.4K Buy
10,084
+10,000
+11,905% +$8.97K ﹤0.01% 5098
2024
Q1 		$67 Sell
84
-838,513
-100% -$763K ﹤0.01% 5509
2023
Q4 		$798K Buy
838,597
+466,176
+125% +$458K ﹤0.01% 3029
2023
Q3 		$402K Buy
372,421
+363,427
+4,041% +$432K ﹤0.01% 3223
2023
Q2 		$8.07K Buy
8,994
+803
+10% +$712 ﹤0.01% 5108
2023
Q1 		$6.92K Sell
8,191
-2,527
-24% -$2.77K ﹤0.01% 4859
2022
Q4 		$9.96K Sell
10,718
-3,087
-22% -$4.12K ﹤0.01% 4841
2022
Q3 		$23K Sell
13,805
-20,776
-60% -$54.4K ﹤0.01% 4687
2022
Q2 		$74K Sell
34,581
-45,749
-57% -$122K ﹤0.01% 4359
2022
Q1 		$285K Sell
80,330
-732,056
-90% -$2.12M ﹤0.01% 3873
2021
Q4 		$3.02M Buy
812,386
+781,914
+2,566% +$4.8M ﹤0.01% 2259
2021
Q3 		$225K Sell
30,472
-52,436
-63% -$449K ﹤0.01% 4061
2021
Q2 		$1.1M Buy
82,908
+79,984
+2,735% +$786K ﹤0.01% 3139
2021
Q1 		$22K Buy
2,924
+2,674
+1,070% +$30.2K ﹤0.01% 5188
2020
Q4 		$4K Buy
+250
New +$2.78K ﹤0.01% 7144

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citigroup's CLOV Position: Q2 2026 in Review

Citigroup increased its Clover Health Investments (CLOV) stake by 519% in Q2 2026, buying an estimated $636K and bringing the position to 223,265 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #3328.

Citigroup first reported a position in CLOV in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.02M in Q4 2021. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Citigroup held 223,265 shares of Clover Health Investments worth $1.17M as of Q2 2026.
  • Citigroup bought 187,181 Clover Health Investments shares in Q2 2026, an estimated $636K.
  • Clover Health Investments made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3328 holding.
  • Citigroup first reported a position in Clover Health Investments in Q4 2020 and has held it in 23 quarters since.
  • Citigroup's Clover Health Investments position peaked at $3.02M in Q4 2021.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.